Literature DB >> 34415399

Inhalational Constrictive Bronchiolitis: The Evolution of our Understanding of this Disease.

Daniel E Banks1, Michael J Morris2.   

Abstract

The case definition of inhalational constrictive bronchiolitis (CB) has changed over the generations. We identify changes in the description of this illness over time associated with different exposures and present the natural history of CB in a case attributed to military burn pit exposure. The initial descriptions of this disease began with nitric acid spills and silage exposures. In these events, there was an acute exposure, typically a short-term resolution of the adverse respiratory events, and then a progression, leading to disability or a respiratory death. The life-saving role of corticosteroid therapy in this situation was recognized. War gas exposures of World War I and then Saddam Hussein's use of sulfur mustard gas in the Iran-Iraq War followed. More recently the findings associated with diacetyl exposure in commercial popcorn workers remained consistent with previously described presentations, but then the clinical presentation in troops returning from deployment to Southwest Asia was very different, yet with the same histologic findings. We recognize unreconciled disparities in the clinical, physiologic, and imaging presentation in those with inhalational bronchiolitis and acknowledge this as perhaps one of the difficult diagnoses in respiratory medicine.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  Airways obstruction; Bronchiolitis; Inhalation exposure

Mesh:

Year:  2021        PMID: 34415399     DOI: 10.1007/s00408-021-00466-2

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  46 in total

1.  Miscellaneous causes of bronchiolitis: inhalational, infectious, drug-induced, and idiopathic.

Authors:  Talmadge E King
Journal:  Semin Respir Crit Care Med       Date:  2003-10       Impact factor: 3.119

2.  Cancers of the respiratory tract in mustard gas workers.

Authors:  D F Easton; J Peto; R Doll
Journal:  Br J Ind Med       Date:  1988-10

Review 3.  Occupational and environmental bronchiolar disorders.

Authors:  Kristin J Cummings; Kathleen Kreiss
Journal:  Semin Respir Crit Care Med       Date:  2015-05-29       Impact factor: 3.119

Review 4.  The emerging spectrum of exposure-related bronchiolitis.

Authors:  Silpa D Krefft; Carlyne D Cool; Cecile S Rose
Journal:  Curr Opin Allergy Clin Immunol       Date:  2018-04

Review 5.  Cryptogenic constrictive bronchiolitis. A clinicopathologic study.

Authors:  M Kraft; R L Mortenson; T V Colby; L Newman; J A Waldron; T E King
Journal:  Am Rev Respir Dis       Date:  1993-10

6.  Silo filler's disease in New York State.

Authors:  F L Zwemer; D S Pratt; J J May
Journal:  Am Rev Respir Dis       Date:  1992-09

7.  Mustard gas exposure and mortality among retired workers at a poisonous gas factory in Japan: a 57-year follow-up cohort study.

Authors:  Kenichi Mukaida; Noboru Hattori; Hiroshi Iwamoto; Yojiro Onari; Yoshifumi Nishimura; Keiichi Kondoh; Tomoyuki Akita; Junko Tanaka; Nobuoki Kohno
Journal:  Occup Environ Med       Date:  2016-08-11       Impact factor: 4.402

8.  Bronchiolitis obliterans in an animal feed worker.

Authors:  B A Spain; O Cummings; J G Garcia
Journal:  Am J Ind Med       Date:  1995-09       Impact factor: 2.214

9.  Five Decades of Global Chemical Terror Attacks: Data Analysis to Inform Training and Preparedness.

Authors:  Michael A DeLuca; Peter R Chai; Eric Goralnick; Timothy B Erickson
Journal:  Disaster Med Public Health Prep       Date:  2020-07-24       Impact factor: 1.385

10.  Mustard gas exposure in Iran-Iraq war - A scientometric study.

Authors:  Zary Nokhodian; Firoozeh ZareFarashbandi; Parisa Shoaei
Journal:  J Educ Health Promot       Date:  2015-08-06
View more
  1 in total

1.  LUNG Year in Review: 2021.

Authors:  Peter V Dicpinigaitis
Journal:  Lung       Date:  2022-01-18       Impact factor: 3.777

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.